Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
|colspan="1" style = "background:#004466;"| | |colspan="1" style = "background:#004466;"| | ||
|colspan="1" style = "background:#004466;"| | |colspan="1" style = "background:#004466;"| | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | |||
|- | |- | ||
|colspan="1" style = "font-size:90%;" |CD10 | |colspan="1" style = "font-size:90%;" |CD10 | ||
Revision as of 17:40, 21 June 2023
| Immunophenotype LPD | |||
|---|---|---|---|
| Marker | CLL | MCL | FL |
| κ/λ | 40:60 (wk) | >80 | 60:80 |
| FMC7 | 20:40 (wk)" | 40:60 | 40:60 |
| CD5 | <5% | ||
| CD10 | |||
| CD11C | |||
| CD19 | |||
| CD20 | |||
| CD23 | |||
| CD25 | wk | ||
| CD38 | |||
| CD43 | |||
| CD79a | wk | ||
| CD103 | |||
| CD138 | |||
| CD200 | |||
Key to table:
Key to colour code Click for link
Key to expression code Click for link